4//SEC Filing
Boyle Scott N 4
Accession 0001662579-24-000104
CIK 0001662579other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:17 PM ET
Size
8.6 KB
Accession
0001662579-24-000104
Insider Transaction Report
Form 4
Boyle Scott N
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2024-11-07+3,750→ 57,669 total - Tax Payment
Common Stock
2024-11-07$6.04/sh−1,102$6,656→ 56,567 total - Exercise/Conversion
Performance Restricted Stock Units
2024-11-07−3,750→ 10,500 totalExp: 2025-02-28→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001913897
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:17 PM ET
- Size
- 8.6 KB